India’s First Indigenous Drug for Sickle Cell Disease

Recently, an Indian pharmaceutical company announced the development of a new drug for Sickle Cell Disease (SCD).

Key Points

  • It is India’s first indigenous hydroxyurea oral solution, which is used for the treatment of sickle cell disease in children.
  • The drug would be the country’s first indigenous, room temperature stable drug for sickle cell disease to be available at only 1% of the global price.
  • The drug will be provided to the government at the cost of Rs. 600, which is nearly 1% of the cost of the medicine currently available globally at Rs. 77,000.
  • Oral syringes would be provided for precise dosage ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy May 2024 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber
Society Watch